A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: The metabolic syndrome no-more-than-additive

European Journal of Preventive Cardiology

Volumn 15, Issue 2, 2008, Pages 190-196

  Fadini, Gian Paolo ^a   Coracina, Anna ^a   Inchiostro, Sandro ^a   Tiengo, Antonio ^a   Avogaro, Angelo ^a   de Kreutzenberg, Saula Vigili ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

atherosclerosis; cardiovascular risk; metabolic syndrome

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY MEDIA; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; FEMALE; HUMAN; INSULIN RESISTANCE; INTIMA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; METABOLISM; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; THICKNESS;

ADULT; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CLUSTER ANALYSIS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 41949087911     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f17bc3     Document Type: Article

References (23)

1. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006; 97: 3A–11A.
2. Khan R, Buse JB, Ferranini E, Stern M. The metabolic syndrome: time for a critical appraisal joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289–2304.
3. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmid MI, East HE, et al The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in Communities Study. Diabetes Care 2005; 28: 385–390.
4. Altman DG, Royston R. The cost of dichotomising continuous variables. BMJ 2006; 332: 1080.
5. Sanchez-Muniz FJ, Cuesta C, San-Felix B. Comparative determinations of low-density-lipoprotein-cholesterol. Rev Esp Fisiol 1992; 48: 271–276.
6. American Diabetes Association. Clinical practice recommendations 1997; 20: 1044–1045.
7. Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, de Kreutzenberg SV. Peripheral blood CD34 + KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 2006; 37: 2277–2282.
8. Lorenz MW, von Kegler S, Markus HS, Sitzer M. Carotid intima–media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37: 87–92.
9. Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B, et al Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.
10. Golden SL, Folsom AR, Coresh J, Sharrett R, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis. The Atherosclerosis Risk in Communities Study. Diabetes 2002; 51: 3069–3076.
11. Roy P, Esteve J. Using relative risk models for estimating synergy between risk factors. Statist Med 1998; 1: 1357–1373.
12. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, Lakatta EG. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004; 43: 1388–1395.
13. Ishizaka N, Ishizaka Y, Hashimoto H, Toda E, Nagai R, Yamakado M, et al Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure. Hypertension 2006; 48: 411–417.
14. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006; 29: 404–409.
15. The DECODE Study. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? Eur J Cardiovasc Prev Rehabil 2007; 14: 192–199.
16. Sundstrom J, Vallhagen E, Riserus U, Byberg L, Zethelius B, Berne C, et al Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 2006; 29: 1673–1674.
17. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi C, Marini F, et al The Metabolic syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004; 52: 52–58.
18. Monami M, Lambertucci L, Ungar A, Pieri M, Masotti G, Marchionni N, Mannucci E. Is the third component of metabolic syndrome really predictive of outcomes in type 2 diabetic patients? Diabetes Care 2006; 29: 2515–2517.
19. Wilson PW, DAgostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066–3072.
20. Pladevell M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, et al A single factor underlies the metabolic syndrome. A confirmatory factor analysis. Diabetes Care 2006; 29: 113–122.
21. Aarabi M, Jackson PR. Coronary risk in South Asians: role of ethnicity and blood sugar. Eur J Cardiovasc Prev Rehabil 2004; 11: 389–393.
22. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z. Cardiovascular disease risk factor levels and their relations to CVD rates in China – results of Sino-MONICA project. Eur J Cardiovasc Prev Rehabil 2004; 11: 275–283.
23. Schwingel A, Nakata Y, Ito LS, Chodzko-Zajko WJ, Shigematsu R, Erb CT, et al A comparison of the prevalence of the metabolic syndrome and its components among native Japanese and Japanese Brazilians residing in Japan and Brazil. Eur J Cardiovasc Prev Rehabil 2007; 14: 508–514.